Free Access
| Issue |
Med Sci (Paris)
Volume 40, Number 11, Novembre 2024
Nos jeunes pousses ont du talent !
|
|
|---|---|---|
| Page(s) | 879 - 881 | |
| Section | Partenariat médecine/sciences - Écoles doctorales - Masters | |
| DOI | https://doi.org/10.1051/medsci/2024157 | |
| Published online | 10 December 2024 | |
- Durník R, Šindlerová L, Babica P, et al. Bile acids transporters of enterohepatic circulation for targeted drug delivery. Molecules 2022 ; 27 : 2961. [Google Scholar]
- Dawson PA, Lan T, Rao A. Bile acid transporters. J Lipid Res 2009 ; 50 : 2340–57. [CrossRef] [PubMed] [Google Scholar]
- de Vries E, Beuers U. Management of cholestatic disease in 2017. Liver Int 2017 ; 37 : 123–9. [CrossRef] [PubMed] [Google Scholar]
- Yang N, Dong YQ, Jia GX, et al. ASBT(SLC10A2): A promising target for treatment of diseases and drug discovery. Biomed Pharmacother 2020 ; 132 : 110835. [CrossRef] [PubMed] [Google Scholar]
- Poupon R, Chignard N, Rosmorduc O, et al. La fonction biliaire et sa régulation. Med Sci (Paris) 2004 ; 20 : 1096–9. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Kunst RF, de Waart DR, Wolters F, et al. Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice. JHEP Rep 2022 ; 4 : 100573. [CrossRef] [PubMed] [Google Scholar]
- Baghdasaryan A, Fuchs CD, Österreicher CH, et al. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis. J Hepatol 2016 ; 64 : 674–81. [CrossRef] [PubMed] [Google Scholar]
- Thompson RJ, Arnell H, Artan R, et al. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol 2022 ; 7 : 830–42. [CrossRef] [PubMed] [Google Scholar]
- Gonzales E, Hardikar W, Stormon M, et al. Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study. Lancet 2021 ; 398 : 1581–92. [CrossRef] [PubMed] [Google Scholar]
- Caballero-Camino FJ, Rodrigues PM, Wångsell F, et al. A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans. Hepatology 2023 ; 78 : 709–26. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.